Evidence map›Paper›PMID 30217188›Full record

ArticleBMC medical genetics2018

Two novel L2HGDH mutations identified in a rare Chinese family with L-2-hydroxyglutaric aciduria.

Wei Peng, Xiu-Wei Ma, Xiao Yang, Wan-Qiao Zhang, Lei Yan, Yong-Xia Wang, Xin Liu, Yan Wang, Zhi-Chun Feng

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC medical genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Wei PengBaiyi Children's Hospital affiliated to PLA Army General Hospital, Beijing, 100700, People's Republic of China.
Xiu-Wei MaBaiyi Children's Hospital affiliated to PLA Army General Hospital, Beijing, 100700, People's Republic of China.
Xiao YangBaiyi Children's Hospital affiliated to PLA Army General Hospital, Beijing, 100700, People's Republic of China.
Wan-Qiao ZhangBaiyi Children's Hospital affiliated to PLA Army General Hospital, Beijing, 100700, People's Republic of China.
Lei YanBaiyi Children's Hospital affiliated to PLA Army General Hospital, Beijing, 100700, People's Republic of China.
Yong-Xia WangBaiyi Children's Hospital affiliated to PLA Army General Hospital, Beijing, 100700, People's Republic of China.
Xin LiuBaiyi Children's Hospital affiliated to PLA Army General Hospital, Beijing, 100700, People's Republic of China.
Yan WangBaiyi Children's Hospital affiliated to PLA Army General Hospital, Beijing, 100700, People's Republic of China. 001wangyan@sina.com.
Zhi-Chun FengBaiyi Children's Hospital affiliated to PLA Army General Hospital, Beijing, 100700, People's Republic of China. zhichunfeng81@163.com.ORCID 0000-0003-2634-0292
Bayi Children's Hospital · CNChinese Center For Disease Control and Prevention · CNBeijing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundL-2-Hydroxyglutaric aciduria (L-2-HGA) is a rare organic aciduria neurometabolic disease that is inherited as an autosomal recessive mode and have a variety of symptoms, such as psychomotor developmental retardation, epilepsy, cerebral symptoms as well as increased concentrations of 2-hydroxyglutarate (2-HG) in the plasma, urine and cerebrospinal fluid. The causative gene of L-2-HGA is L-2-hydroxyglutarate dehydrogenase gene (L2HGDH), which consists of 10 exons. CASE PRESENTATION: We presented a rare patient primary diagnosis of L-2-HGA based on the clinical symptoms, magnetic resonance imaging (MRI), and gas chromatography-mass spectrometry (GC-MS) results. Mutational analysis of the L2HGDH gene was performed on the L-2-HGA patient and his parents, which revealed two novel mutations in exon 3: a homozygous missense mutation (c.407 A > G, p.K136R) in both the maternal and paternal allele, and a heterozygous frameshift mutation [c.407 A > G, c.408 del G], (p.K136SfsX3) in the paternal allele. The mutation site p.K136R of the protein was located in the pocket of the FAD/NAD(P)-binding domain and predicted to be pathogenic.

conclusionWe predicted the homozygous missense mutation (c.407 A > G, p.K136R) was considered as the pathogenic mutation of the patient. The study highlights the power of pedigree analysis in order to interpret novel mutations.

Indexed as

Frameshift MutationMutation, MissenseAlcohol OxidoreductasesBase SequenceBrain Diseases, Metabolic, InbornDNA Mutational AnalysisExonsFemaleFlavin-Adenine DinucleotideGene ExpressionGenes, RecessiveHeterozygoteHomozygoteHumansInfantMagnetic Resonance ImagingAlcohol OxidoreductasesFlavin-Adenine DinucleotideL2HGDH protein, humanNADPL2HGDHL-2-Hydroxyglutaric aciduriaMutation

Identifiers

PMID30217188
PMCPMC6137868
OpenAlexW2889880279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.